ESTRO Brachytherapy for Prostate Cancer 2018

445 / 884

IPSS Post Monotherapy
1mo 3mo 6mo 12mo 24mo
N 209 192 198 190 105
Median 9 7 6 6 6
Range 0-34 0-31 0-34 0-33 0-28
0
5
10
15
20
25
30
35
40
45
50
1mo 3mo 6mo 12mo 24mo
IPSS >10 (%) IPSS >20 (%)
%